CRISPLD1 and neoplasm: Abnormal expression of CRISPLD1 has been observed in various cancers, including acute myeloid leukemia (AML), renal cell carcinoma, and endometrial cancer, suggesting its potential as a biomarker in tumor diagnosis [[11], [12], [13]].